Lumen Bioscience takes in $16m Series B
Seattle-based Lumen Bioscience, a biopharmaceutical company, has raised $16 million in Series B funding.
Seattle-based Lumen Bioscience, a biopharmaceutical company, has raised $16 million in Series B funding.
Copyright PEI Media
Not for publication, email or dissemination